Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PSI Appoints Oral Formulation Director | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

PSI Appoints Oral Formulation Director

Gwozdz to head product development efforts

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Robert Gwozdz has been appointed director of oral formulation at Particle Sciences, Inc. (PSI). Mark Mitchnick, chief executive officer of PSI, said, “PSI has a broad array of drug delivery technologies applicable across many dosage forms and drug types. About 25% of our work is on oral products. The client base now warrants a dedicated director for oral product development. Robert has a vast amount of experience having come from the generics industry and having been key on approximately 30 ANDAs.”

Mr. Gwozdz said, “Having been with one of the largest generic companies, I have had the luxury of exposure to virtually every current delivery strategy. I’m really looking forward to leveraging PSI’s technology portfolio for both new chemical entities and life-cycle extension challenges. The approaches to both these challenges have substantially merged over the last few years and PSI is perfectly positioned to leverage this.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics